Evidence map›Paper›PMID 21963004›Full record

ReviewLancet (London, England)2012

Effective tobacco control is key to rapid progress in reduction of non-communicable diseases.

Stanton Glantz, Mariaelena Gonzalez

Abstract readReview
In one paragraph

Review in Lancet (London, England), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Estimating the Cost of Delivering Tobacco Cessation Intervention Package at Noncommunicable Disease Clinics in Two Districts of North India.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023
    Article
  9. Review
  10. Article
  11. Pathway analysis of smoking-induced changes in buccal mucosal gene expression.The Egyptian journal of medical human genetics · 2022
    Article
  12. Article
  13. Article
  14. Testing Club Convergence in Female Smoking Prevalence.Frontiers in global women's health · 2022
    Article
  15. Article
  16. Unravelling the mechanisms driving multimorbidity in COPD to develop holistic approaches to patient-centred care.European respiratory review : an official journal of the European Respiratory Society · 2021
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Stanton GlantzCenter for Tobacco Control Research and Education, Cardiovascular Research Institute, Department of Medicine, University of California San Francisco, San Francisco, CA 94143-1390, USA.
Mariaelena Gonzalez

Funding

TOBACCO ADVOCACY AT THE STATE LEVELR01CA061021 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GLANTZ, STANTON ARNOLD · 1994 to 2015
$7.4M
Postdoctoral training in tobacco controlR25CA113710 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GLANTZ, STANTON ARNOLD · 2006 to 2015
$5.4M
Postdoctoral training in tobacco controlT32CA113710 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LING, PAMELA MAY · 2016 to 2020
$2.6M
NCI NIH HHS CA-113710NCI NIH HHS CA-61021NCI NIH HHS R01 CA061021NCI NIH HHS R25 CA113710NCI NIH HHS T32 CA113710
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Tobacco Use CessationCardiovascular DiseasesCause of DeathChronic DiseaseCross-Cultural ComparisonDiabetes Mellitus, Type 2Health Plan ImplementationHumansNeoplasmsPulmonary Disease, Chronic ObstructiveRisk FactorsSmokingSmoking CessationSmoking PreventionSocioeconomic FactorsTobacco IndustryTobacco Smoke Pollution

Identifiers

PMID21963004
PMCPMC3260384

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.